2. Investigations of sources of heterogeneity for studies of visual inspection for detection of BCC.
Test | Datasets | Lesions (BCCs) |
DOR (95% CI) |
Specificity at 80% sensitivity | Sensitivity at 80% specificity | Relative DOR (95% CI) | P value (LR)a | P value (Wald)b |
Difference in‐person and image based | ||||||||
In‐person | 8 | 7017 (1586) |
11.9 (4.4 to 32.2) |
64% | 74% | 0.45 (0.26 to 9.2) |
0.88 | 0.62 |
Image | 4 | 853 (156) |
18.5 (4.3 to 80.6) |
78% | 79% | |||
Prevalence | ||||||||
0% ‐ 25% | 6 | 4643 (168) |
50.5 (17.1 to 149) |
94% | 91% | 9.7 (2.3 to 40.8) |
0.002 | 0.002 |
> 25% | 6 | 3227 (1574) |
5.2 (2.3 to 11.7) |
50% | 60% |
BCC ‐ basal cell carcinoma; DOR ‐ diagnostic odds ratio; RDOR ‐ relative diagnostic odds ratio; CI ‐ confidence interval; LR ‐ likelihood ratio
aTests whether there is a difference in test performance between defined groups in terms of either DOR or threshold. bTests the significance of the difference in DOR between defined groups at a particular SROC curve intercept value.